Clinical Trials Directory

Trials / Unknown

UnknownNCT01411371

Catheter Ablation Versus Medical Treatment of AF in Heart Failure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Barts & The London NHS Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure and atrial fibrillation (AF) often coexist, and each increases the morbidity and mortality associated with the other. The investigators hypothesized that restoration of normal sinus rhythm by catheter ablation is superior to medical treatment of AF in heart failure. This study randomizes patients with heart failure and persistent AF to medical treatment of AF or catheter ablation to restore sinus rhythm.

Conditions

Interventions

TypeNameDescription
PROCEDURECatheter ablation of persistent atrial fibrillationCatheter ablation of AF as described previously by our group (e.g. Hunter et al, Heart 2010).
DRUGMedical treatment aloneMedical treatment of persistent AF as 'normal care'. Patients are randomised to medical treatment alone for atrial fibrillation. Treatment will be as per current guidelines for persistent atrial fibrillation, with rate control as first line (using beta-blockers, calcium channel blockers and digoxin as indicated) and rhythm control as second line (using sotalol, dronedarone, or amiodarone as indicated). (Both groups will receive standard heart failure medication including angiotensin converting enzyme inhibitors, beta blockers, aldosterone antagonists, and diuretics as indicated).

Timeline

Start date
2005-03-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2011-08-08
Last updated
2011-08-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01411371. Inclusion in this directory is not an endorsement.